Publications

5891 Results

External Validation of the locked ArteraAI Breast MMAI model for Prognosis and Chemotherapy Benefit Prediction in Postmenopausal, Node-Positive, Hormone Receptor-Positive Breast Cancer Patients: Analysis of SWOG S8814

Authors
Speers CW
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 107 oral
Year
2026
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

DART (NCI/SWOG S1609): Comprehensive Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers

Authors
Patel SP
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il);
abs 2502 oral
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Outcomes of Patients with Rare Cancers Treated with Combination Immune Checkpoint Inhibitors With and Without Lung and/or Liver Metastases (NCI/SWOG S1609)

Authors
Othus M
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 2633 poster
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Post-Treatment Recovery Patterns among Patients with Early-Stage Cancer who Develop Taxane-Induced Peripheral Neuropathy (TIPN): SWOG S1714 (NCT03939481)

Authors
Trivedi M;Unger JM;Hertz DL;Till C;Brannagan T;Smith S;Schneider BP;Irvin WJ;Hathaway AR;Vander Woude AC;Gudena VK;Cabrera-Galeana PA;Orsted M;LeBlanc ML;Fisch MJ;Henry NL;Hershman DL
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 12117 poster
Year
2026
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1714

Vitamin D insufficiency and risk of taxane-induced peripheral neuropathy: Results from SWOG S1714

Authors
Nguyen-Hoang N;Henry NL;Hershman DL;Trivedi MS;Hertz DL
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 12012 rapid oral
Year
2026
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1714

First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer

Authors
Nappi L;Colby S;Hamilton RW;Harzstark A;Adra N;Daneshmand S;Ryan CW;Eggener SE;Fung C;Johnson R;Lerner SP;Arnold KB;Arun B;Rae JM;Blanke CD;LeBlanc ML;Parulekar WR;Einhorn LH;Kollmannsberger CK;Nichols CR
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs LBA5003 oral; J Clin Oncol 44, 2026 (suppl 17; abstr LBA5003) DOI: 10.1200/JCO.2026.44.17_suppl.LBA5003
Year
2026
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S1823

Baseline Financial and Credit Status of Participants Enrolled in SWOG S1912CD

Authors
Shankaran V;Bell-Brown A;Darke A;Hopkins T;Watabayashi K;Unger JM;Dzingle S;Carlos R;Langer S;Hershman DL;Ramsey SD
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 11049 poster
Year
2026
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1912CD

Randomized Phase II Trial of Olaparib + Pembrolizumab vs Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 (gBRCA1/2) Mutations: SWOG S2001

Authors
Chung V
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 4012 rapid oral
Year
2026
Research Committee(s)
Gastrointestinal
Study Number(s)
S2001

Associations between self-efficacy and symptom burden in young women with breast cancer initiating endocrine therapy (ET) on SWOG S2010

Authors
Henry NL;Darke A;Unger JM;Schott A;Kumar P;Mazo Canola M;Sathe C;Cabrera-Galeana P;Kengla A;Fisch MJ;Hershman DL
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 521 poster
Year
2026
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S2010

Immune Checkpoint Inhibitor (ICI) Toxicity in a Large Prospective Cohort of Patients with Solid Tumors: The I-CHECKIT Study (SWOG S2013)

Authors
Gunturu K;Unger JM;Hershman DL;Darke A;Kuderer N;Wei AZ;Hu-Lieskovan S;Walshauser M;Nabi J;Fisch MJ;Henry NL
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 2640 poster
Year
2026
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S2013